12:08 AM EDT, 08/20/2026 (MT Newswires) -- Novonesis' (NSIS-B.CO) board approved a 1 billion-euro share repurchase program, according to a Wednesday release. The multi-year share repurchase program will commence in the second half of 2026, with completion expected by the end of 2029. The Danish biosolutions company plans to cancel the majority of the repurchased shares, while retaining some to satisfy obligations under its employee share-based incentive programs.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.